GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,042,000 | +3.2% | 138,700 | +4.4% | 0.32% | -4.8% |
| Q4 2021 | $5,856,000 | +12.9% | 132,800 | -2.2% | 0.33% | +7.4% |
| Q3 2021 | $5,189,000 | -5.6% | 135,800 | -1.6% | 0.31% | +1.6% |
| Q2 2021 | $5,495,000 | +11.6% | 138,000 | 0.0% | 0.30% | +6.6% |
| Q1 2021 | $4,925,000 | +25.5% | 138,000 | +29.5% | 0.29% | +13.5% |
| Q4 2020 | $3,923,000 | -7.7% | 106,600 | -5.6% | 0.25% | -14.9% |
| Q3 2020 | $4,250,000 | -9.8% | 112,900 | -2.3% | 0.30% | -9.8% |
| Q2 2020 | $4,711,000 | +5.7% | 115,500 | -1.8% | 0.33% | -2.1% |
| Q1 2020 | $4,456,000 | -18.5% | 117,600 | +1.1% | 0.34% | +20.5% |
| Q4 2019 | $5,465,000 | +5.1% | 116,300 | -4.5% | 0.28% | +6.5% |
| Q3 2019 | $5,198,000 | +3.8% | 121,800 | -2.6% | 0.26% | +8.8% |
| Q2 2019 | $5,007,000 | -4.2% | 125,100 | 0.0% | 0.24% | -1.2% |
| Q1 2019 | $5,228,000 | -8.7% | 125,100 | -16.5% | 0.24% | -13.5% |
| Q4 2018 | $5,728,000 | -8.1% | 149,900 | -3.4% | 0.28% | +22.2% |
| Q3 2018 | $6,234,000 | -0.4% | 155,200 | 0.0% | 0.23% | +7.5% |
| Q2 2018 | $6,256,000 | +3.2% | 155,200 | 0.0% | 0.21% | +4.9% |
| Q1 2018 | $6,064,000 | +36.3% | 155,200 | +23.8% | 0.20% | +48.9% |
| Q4 2017 | $4,448,000 | -12.6% | 125,400 | 0.0% | 0.14% | -13.3% |
| Q3 2017 | $5,091,000 | -5.8% | 125,400 | 0.0% | 0.16% | -4.8% |
| Q2 2017 | $5,407,000 | -1.2% | 125,400 | -3.4% | 0.17% | +3.1% |
| Q1 2017 | $5,472,000 | +139.8% | 129,800 | +143.1% | 0.16% | +147.7% |
| Q4 2014 | $2,282,000 | -7.0% | 53,400 | 0.0% | 0.06% | -11.0% |
| Q3 2014 | $2,455,000 | -17.1% | 53,400 | -3.6% | 0.07% | -20.7% |
| Q2 2014 | $2,963,000 | +9.8% | 55,400 | +9.7% | 0.09% | -8.0% |
| Q1 2014 | $2,698,000 | -8.4% | 50,500 | -8.5% | 0.10% | -16.7% |
| Q4 2013 | $2,947,000 | +4.7% | 55,200 | -1.6% | 0.12% | -5.5% |
| Q3 2013 | $2,815,000 | +0.4% | 56,100 | 0.0% | 0.13% | -9.3% |
| Q2 2013 | $2,803,000 | – | 56,100 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |